Your browser doesn't support javascript.
loading
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis.
Curigliano, G; Mueller, V; Borges, V; Hamilton, E; Hurvitz, S; Loi, S; Murthy, R; Okines, A; Paplomata, E; Cameron, D; Carey, L A; Gelmon, K; Hortobagyi, G N; Krop, I; Loibl, S; Pegram, M; Slamon, D; Ramos, J; Feng, W; Winer, E.
Affiliation
  • Curigliano G; Istituto Europeo di Oncologia, Milan, IRCCS and University of Milano, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.
  • Mueller V; Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Borges V; University of Colorado Hospital, Aurora, USA.
  • Hamilton E; Sarah Cannon Research Institute/Tennessee Oncology - Nashville, Nashville, USA.
  • Hurvitz S; University of California, Los Angeles/Jonsson Comprehensive Cancer Center, Los Angeles, USA.
  • Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Murthy R; MD Anderson Cancer Center, Houston, USA.
  • Okines A; The Royal Marsden NHS Foundation Trust, London, UK.
  • Paplomata E; Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, USA.
  • Cameron D; Edinburgh Cancer Research Centre, Edinburgh, UK.
  • Carey LA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA.
  • Gelmon K; British Columbia Cancer - Vancouver Centre, Vancouver, Canada.
  • Hortobagyi GN; MD Anderson Cancer Center, Houston, USA.
  • Krop I; Dana-Farber Cancer Institute, Boston, USA.
  • Loibl S; German Breast Group, Neu-Isenburg, Germany.
  • Pegram M; Stanford Cancer Institute, Palo Alto, USA.
  • Slamon D; University of California, Los Angeles/Jonsson Comprehensive Cancer Center, Los Angeles, USA.
  • Ramos J; Seagen Inc., Bothell, USA.
  • Feng W; Seagen Inc., Bothell, USA.
  • Winer E; Dana-Farber Cancer Institute, Boston, USA.
Ann Oncol ; 33(3): 321-329, 2022 03.
Article in En | MEDLINE | ID: mdl-34954044

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms Type of study: Clinical_trials / Guideline Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms Type of study: Clinical_trials / Guideline Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: